MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

  • PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease

    JL. Li, CC. Chan, CH. Lin (New Taipei City, Taiwan)

  • Planning for the Parkinson’s Pandemic: Care needs in Australian Residential Aged Care Facilities

    J. Mcginley, S. Soh, Y. Mok, M. Callisaya, V. Mcconvey, M. Klaic, A. Vogel, D. Koye, D. Finkelstein, K. Bower (Parkville, Australia)

  • Plasma Biomarkers Predict Clinical Outcomes in Individuals with Neuronal α-Synuclein Disease and Amyloid-β Co-Pathology

    S. Lorkiewicz, C. Abdelnour, A. Smith, N. Siddiqui, L. Montoliu-Gaya, E. Wilson, N. Ashton, B. Arslan, M. Plastini, C. Young, J. Winer, M. Shahid-Besanti, H. Vossler, V. Ramirez, G. Kerchner, K. Andreasson, V. Henderson, T. Montine, L. Tian, E. Mormino, H. Zetterberg, K. Poston (Gothenburg, Sweden)

  • Plasma Lipids as Potential Biomarkers for Progression of Sleep Disturbances in Parkinson’s Disease

    M. Mchorney, R. Rajhmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

  • Plasma Neurofilament Light Chain and Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder: A Biomarker for α-Synucleinopathy Progression

    A. Calculli, D. Di Martino, P. Grillo, G. Bellini, C. Fazio, D. Comolli, D. Hoxhaj, S. Cerri, M. Terzaghi, A. Pisani (Pavia, Italy)

  • Plasma neurofilament light chain in early Parkinson’ s disease predicts motor complications: A Prospective Cohort Study

    NN. Che (Chengdu, Sichuan, China)

  • Plasma P-tau217 detects Alzheimer’s co-pathology and predicts cognitive decline in Parkinson’s disease

    T. Tropea, P. Aldea Stevenson, M. Flitter, D. Meehan, A. Morris, M. Lu, L. Iaccarino, E. Collins, M. Hodsdon, L. Shaw, E. Lee, D. Weintraub, A. Chen-Plotkin, M. Mintun, A. Siderowf (Philadelphia, USA)

  • Plasma Protein Profiles Reveal Distinct Molecular Signatures in Parkinson’s Disease and Multiple System Atrophy

    SJ. Chung, S. Jo, I. Jang, J. Lee, M. Choi, E. Lee (Seoul, Republic of Korea)

  • Plasma proteomic profiles and risk of Parkinson’s disease: a prospective study from UK Biobank

    C. Li, B. Ke, X. Zheng, Y. Xiao, S. Wang, Q. Jiang, J. Lin, J. Huang, H. Shang (Chengdu, China)

  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley